TH.TO
Price:
$1.61
Market Cap:
$55.74M
Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients. Its pipeline products include F8 Formulation for the treatment of lipodystrophy in people living with HIV; TH1902, which is in Phase 1/Part A clinical trials for the treatment of triple negative breast cancer; and TH1904 for ...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
1996-08-06
Stock Exchange
TSX
Ticker
TH.TO
According to Theratechnologies Inc.’s latest financial reports and current stock price. The company's current ROE is 25.35%. This represents a change of 250.22% compared to the average of 7.24% of the last 4 quarters.
The mean historical ROE of Theratechnologies Inc. over the last ten years is -80.83%. The current 25.35% ROE has changed -131.36% with respect to the historical average. Over the past ten years (40 quarters), TH.TO's ROE was at its highest in in the May 2022 quarter at 195.18%. The ROE was at its lowest in in the November 2020 quarter at -172.12%.
Average
-80.83%
Median
-27.85%
Minimum
-703.07%
Maximum
209.28%
Discovering the peaks and valleys of Theratechnologies Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 898.52%
Maximum Annual ROE = 209.28%
Minimum Annual Increase = -2906.22%
Minimum Annual ROE = -703.07%
Year | ROE | Change |
---|---|---|
2023 | 114.79% | -45.15% |
2022 | 209.28% | -217.16% |
2021 | -178.63% | -74.59% |
2020 | -703.07% | 898.52% |
2019 | -70.41% | 445.02% |
2018 | -12.92% | -69.81% |
2017 | -42.79% | -2906.22% |
2016 | 1.52% | -80.57% |
2015 | 7.85% | -105.86% |
2014 | -133.97% | 512.15% |
The current ROE of Theratechnologies Inc. (TH.TO) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
48.48%
5-year avg
-125.61%
10-year avg
-80.83%
Theratechnologies Inc.’s ROE is
Company | ROE | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Theratechnologies Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Theratechnologies Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Theratechnologies Inc.'s ROE?
How is the ROE calculated for Theratechnologies Inc. (TH.TO)?
What is the highest ROE for Theratechnologies Inc. (TH.TO)?
What is the 3-year average ROE for Theratechnologies Inc. (TH.TO)?
What is the 5-year average ROE for Theratechnologies Inc. (TH.TO)?
How does the current ROE for Theratechnologies Inc. (TH.TO) compare to its historical average?